MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Device: CRT with MultiPoint PacingProcedure: Hemodynamic measurements for CRT device programming
- Registration Number
- NCT02064751
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
The purpose of this study is to evaluate noninvasive hemodynamics with MultiPoint™ Pacing (MPP) and biventricular (BiV) pacing under various vector combinations and paced delays in patients receiving cardiac resynchronization therapy (CRT).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Be scheduled to undergo de novo implant of a St. Jude Medical CRT-D system
- Be in NYHA II or III functional class with approved standard indication by ESC/EHRA Guidelines
- Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule
Exclusion Criteria
- Have persistent or permanent atrial fibrillation
- Have a recent myocardial infarction within 40 days prior to enrollment
- Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 12 months
- Have had a recent Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) within 3 months prior to enrollment
- Have had intravenous inotropic support in the last 30 days
- Be scheduled or considered for heart transplantation over the next 12 months
- Be less than 18 years of age
- Be pregnant or plan to become pregnant over the next 12 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MultiPoint Pacing Hemodynamic measurements for CRT device programming CRT with MultiPoint Pacing MultiPoint Pacing CRT with MultiPoint Pacing CRT with MultiPoint Pacing
- Primary Outcome Measures
Name Time Method Systolic blood pressure changes in hemodynamics during BiV pacing and MPP up to 6-months
- Secondary Outcome Measures
Name Time Method echocardiographic changes to MPP programming guided by noninvasive hemodynamic measurements 6 months End systolic volume will be assessed at 6-month follow-up visit and compared to that of baseline.
Trial Locations
- Locations (4)
CHU Rennes
🇫🇷Rennes, France
Fondazione IRCCS Policlinico San Matteo
🇮🇹Pavia, Italy
Medizinische Universität Graz
🇦🇹Graz, Austria
Niguarda Hospital
🇮🇹Milan, Italy